8-K 1 mm07-1310_8k.htm FORM 8-K mm07-1310_8k.htm

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 


 
FORM 8-K
 
 

 

 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
 
Date of Report (date of earliest event reported): July 13, 2010
 
 
 

 

Gentiva Health Services, Inc.
(Exact Name of Registrant as Specified in Its Charter)
 

 

 
         
Delaware
  
1-15669
  
36-4335801
(State or Other Jurisdiction of Incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No.)
 
     
3350 Riverwood Parkway, Suite 1400
Atlanta, Georgia
  
 
30339-3314
(Address of principal executive offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (770) 951-6450
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

 
 

 


Item 8.01
  Other Events
 
On July 13, 2010, Gentiva Health Services, Inc., a Delaware corporation (“Gentiva”), issued a press release.  A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 8.01.

 
Item 9.01.
Financial Statements and Exhibits.
 
(d)
Exhibits.
 
 
Exhibit No.
Description
   
99.1
Press Release, dated July 13, 2010
 

 

 



 

 




 
2

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: July 13, 2010
         
   
GENTIVA HEALTH SERVICES, INC.
     
   
By:
 
/S/    JOHN N. CAMPERLENGO        
       
John N. Camperlengo
       
Senior Vice President, General Counsel
       
Chief Compliance Officer and Secretary
 
 
 

 

 
3

 


 

EXHIBIT INDEX
 
 
Exhibit Number
Description
 
 
99.1
Press Release, dated July 13, 2010
 
 
 
 
 
 
 

 

 
4